Skip to main content
Contact Us
Subscribe
E-Edition
71°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Curis, Inc. - Common Stock
(NQ:
CRIS
)
1.310
+0.020 (+1.55%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Curis, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
Curis's Return On Capital Employed Overview
March 15, 2023
Via
Benzinga
A Preview Of Curis's Earnings
March 10, 2023
Via
Benzinga
Earnings Preview For Curis
March 08, 2023
Via
Benzinga
Why Hertz Global Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
March 06, 2023
Gainers Secoo Holding Limited (NASDAQ: SECO) rose 44% to $1.44 in pre-market trading after dipping over 31% on Friday.
Via
Benzinga
Looking Into Curis's Return On Capital Employed
December 15, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
December 12, 2022
Via
Benzinga
Why Is Curis (CRIS) Stock Up 20% Today?
August 18, 2022
Curis just received a regulatory nod for its lymphoma treatment study from the FDA. Now CRIS stock traders are buying today.
Via
InvestorPlace
FDA Clears Curis' Lymphoma Study, Keeping Leukemia Trial Still Stalled
August 18, 2022
Via
Benzinga
Curis Shares Gain On Encouraging Data Presentation From Blood Cancer Trials At ASCO Meeting
June 06, 2022
Via
Benzinga
Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
December 13, 2022
Gainers OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial.
Via
Benzinga
Earnings Outlook For Curis
November 08, 2022
Curis (NASDAQ:CRIS) is set to give its latest quarterly earnings report on Wednesday, 2022-11-09. Here's what investors need to know before the announcement. Analysts estimate that Curis will report an...
Via
Benzinga
Why Harpoon Therapeutics Shares Are Trading Higher By 97%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
December 12, 2022
Gainers HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) shares jumped 165.7% to $1.4350 after jumping around 118% on Friday. HTG Molecular Diagnostics, last month, posted a Q3 loss of $0.41 per share.
Via
Benzinga
Why Golden Ocean Group Is Trading Higher By 7%; Here Are 28 Stocks Moving Premarket
September 26, 2022
Gainers
Via
Benzinga
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
August 30, 2022
Via
Benzinga
Curis Resumes Enrollment In Monotherapy TakeAim Leukemia Study, Combo Phase Still Under Partial Hold
August 30, 2022
The FDA has notified Curis Inc (NASDAQ: CRIS) to resume enrollment of additional patients in the monotherapy phase of the TakeAim Leukemia study of Emavusertib.
Via
Benzinga
Curis's Return On Capital Employed Insights
August 24, 2022
According to Benzinga Pro data, during Q2, Curis (NASDAQ:CRIS) posted sales of $2.39 million. Earnings were up 1.05%, but Curis still reported an overall loss of $15.94 million.
Via
Benzinga
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
August 18, 2022
Via
Benzinga
Analyzing Curis Short Interest
August 18, 2022
Curis (NASDAQ:CRIS) short percent of float has fallen 4.29% since its last report. The company recently reported that it has 3.58 million shares sold short, which is...
Via
Benzinga
This Biotechnology Stock Tumbled 37%; Here Are 70 Biggest Movers From Yesterday
August 19, 2022
Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares climbed 135.9% to close at $2.17 on Thursday.
Via
Benzinga
Dow Falls 60 Points; Crude Oil Rises Sharply
August 18, 2022
U.S. stocks traded mixed toward the end of trading, with the Dow Jones dropping around 60 points on Thursday.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
August 18, 2022
Via
Benzinga
Why Plus Therapeutics Is Trading Higher By Over 50%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session
August 18, 2022
Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 297% to $3.66.
Via
Benzinga
BLUE Stock Moves as FDA Approves Bluebird Bio’s Gene Therapy
August 18, 2022
Bluebird Bio (BLUE) stock is on the move Thursday following FDA approval for beta-thalassemia treatment ZYNTEGLO in adults and children.
Via
InvestorPlace
U.S. Stocks Turn Higher; Nasdaq Rises 50 Points
August 18, 2022
U.S. stocks turned higher midway through trading, with the Nasdaq Composite gaining 50 points on Thursday.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
August 18, 2022
Via
Benzinga
6 Penny Stocks With 1,000% Upside Potential
July 24, 2022
Each of these penny stocks with 1,000% upside potential could rise 10X in the future for investors with a high risk tolerance.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
June 06, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
June 06, 2022
Welcome back and get ready for another week of trading as we start it with the biggest pre-market stock movers for Monday!
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Intraday Session
June 03, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
May 31, 2022
On Tuesday, 36 companies achieved new lows for the year.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.